Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2021-A02428-33 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this study is to adapt the Canadian French version of the safety assessment scale for use in France. The Safety Assessment Scale was developped for community healthcare providers working with elderly people with dementia who are being cared for at home, to assess the risk of accidents. The short version of the Safety Assessment Scale is a screening tool and the longer version provides an in-depth evaluation of safety.
This scale is a risk assessment grid for accidents and injuries at home for elderly people with major neurocognitive disorders, available in English and French (Canadian). There are two versions:
The short version is used for screening. A score of 11 to 14 indicates a moderate risk of injury, while a score ≥ 15 indicates a high risk of injury;
The long version is used for in-depth assessment when the score on the short version indicates a moderate or high risk of injury. The questionnaire is divided into nine sections:
The short version includes some of the questions from sections 1 to 7 of the long version.
Secondary objectives:
The other objectives of this study are to assess the test-retest reliability and the inter-rater reliability of the translated scale and to evaluate the internal consistency of the long version of the translated scale.
Conduct of research:
Caregivers of patients with major neurocognitive disorders included in the study will complete the adapted scale with an investigator. A pre-test phase will be carried out with 10 caregivers: the caregivers will complete the questionnaire only once with an investigator.
After this phase, the translated Safety Assessment Scale will be corrected if there are difficulties in understanding certain words or sentences. The new scale will then be evaluated on two cohorts of 53 caregivers (cohort 1: caregivers will complete the adapted scale twice with the same investigator; cohorte 2: caregivers will complete the adapted scale twice with two different investigators).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Test Phase : Test-Retest Reliability | Caregivers will complete the questionnaire twice with the same investigator. The interval between the two questionnaires is 3 to 10 days. |
| |
| Test Phase : Inter-rater Reliability | Caregivers will complete the questionnaire twice with two different investigators. The interval between the two questionnaires is 3 to 10 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Questionnaire : Adapted Safety Assessment Scale | Other | Patients caregivers will complete the questionnaire twice : once at enrollment, then 3 to 10 days after enrollment. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Test-retest Reliability | The caregiver will complete the questionnaire (adapted Safety Assessment Scale) twice with the same investigator | 10 days |
| Measure | Description | Time Frame |
|---|---|---|
| Inter-rater Reliability | The caregiver will complete the questionnaire (adapted Safety Assessment Scale) twice with two different investigators. | 10 days |
| Internal consistency of the long version of the adapted Safety Assessment Scale |
Not provided
Inclusion Criteria:
Patient living at home or hospitalized with a planned return home
Patient with a major neurocognitive disorder (Diagnostic and Statistical Manual of Mental Disorders, fifth version) :
Patient with at least one caregiver:
No objection to participating in the study from the caregiver and the patient (if able to understand the study)
No objection to guardian participation for patients under guardianship or curatorship
Exclusion Criteria:
Not provided
Not provided
Not provided
Caregivers of elderly people with a major neurocognitive disorder living at home. Caregivers will be selected by healthcare professionals working in geriatric care.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clémence BONNOT, Occupational Therapist | Groupe Hospitalier de la Region de Mulhouse et Sud Alsace | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GHRMSA | Mulhouse | 68100 | France |
Not provided
| Label | URL |
|---|---|
| Link to the article | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The internal consistency of the items will be evaluated within each of the 9 sections of the scale by calculating the Cronbach's alpha coefficient.
| 10 days |
| ID | Term |
|---|---|
| D003704 | Dementia |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided